Mpm Bioventures 2018, L.P. sold $1.9M of Entrada Therapeutics, Inc. (TRDA) stock

Mpm Bioventures 2018, L.P., 10% owner of Entrada Therapeutics, Inc. (TRDA), sold 259,837 shares of TRDA stock worth $1.9M, per an SEC Form 4 filed Sep 9, 2026.

It was an open-market sale.

The trade happened on Sep 4, 2026, 5 days before it was made public.

TRDA has moved -20.5% since the trade date, from $7.13 to $5.67 (Oct 9, 2026 close).